Evan J. Lipson

Sitert av

	Alle	Siden 2020
Sitater	23964	14404
h-indeks	58	50
i10-indeks	106	96

2900

1450

725

2175

2013201420152016201720182019202020212022202320242025108 409 1008 1434 1933 2045 2296 2648 2703 2864 2796 2857 488

Offentlig tilgang

Vis alle

69 artikler

1 artikkel

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

janis taubeProfessor of Dermatology, Pathology, and Oncology, Johns Hopkins University SOMVerifisert e-postadresse på jhmi.edu
Suzanne TopalianJohns Hopkins University School of MedicineVerifisert e-postadresse på jhmi.edu
Andrew PardollJohns Hopkins University school of medicineVerifisert e-postadresse på jhmi.edu
Paolo A. AsciertoIstituto Nazionale Tumori Fondazione "G. Pascale", Napoli, ItalyVerifisert e-postadresse på istitutotumori.na.it
Jarushka NaidooAssistant Professor of Oncology, Johns Hopkins UniversityVerifisert e-postadresse på jhmi.edu
Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore HospitalVerifisert e-postadresse på sydney.edu.au
Dirk SchadendorfProfessor für Dermatologie, University Hospital Essen; University of Duisburg-EssenVerifisert e-postadresse på uk-essen.de
Jean Jacques GrobPr Dermatolgy and Skin CancersVerifisert e-postadresse på ap-hm.fr
Patrick FordeJohns Hopkins UniversityVerifisert e-postadresse på jhmi.edu
Dung LeJohns Hopkins UniversityVerifisert e-postadresse på jhmi.edu
Helen GogasNational and Kapodistrian University of AthensVerifisert e-postadresse på med.uoa.gr
Robert A. AndersJohns HopkinsVerifisert e-postadresse på jhmi.edu
Laura C. CappelliAssociate Professor of Medicine & OncologyVerifisert e-postadresse på jhmi.edu
Michael AtkinsGeorgetown-Lombardi Comprehensive Cancer CtrVerifisert e-postadresse på georgetown.edu
Richard D. CarvajalNorthwell Health Cancer InstituteVerifisert e-postadresse på northwell.edu
Igor PuzanovRoswell Park Cancer InstituteVerifisert e-postadresse på roswellpark.org
Clifton BinghamJohns Hopkins UniversityVerifisert e-postadresse på jhmi.edu
Tricia CottrellQueen's UniversityVerifisert e-postadresse på queensu.ca
Lawrence R KleinbergVerifisert e-postadresse på jhmi.edu
Charles G. DrakeImmunologyVerifisert e-postadresse på jhmi.edu

Følg

Evan J. Lipson

Associate Professor of Oncology, Johns Hopkins University

Verifisert e-postadresse på jhmi.edu - Startside

Melanoma Skin Cancer Immunotherapy Organ transplant-related cancer


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Detection of circulating tumor DNA in early-and late-stage human malignancies C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... Science translational medicine 6 (224), 224ra24-224ra24, 2014	5135	2014
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab SL Topalian, M Sznol, DF McDermott, HM Kluger, RD Carvajal, ... Journal of clinical oncology 32 (10), 1020-1030, 2014	2777	2014
Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma HA Tawbi, D Schadendorf, EJ Lipson, PA Ascierto, L Matamala, ... New England Journal of Medicine 386 (1), 24-34, 2022	1420	2022
PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma PT Nghiem, S Bhatia, EJ Lipson, RR Kudchadkar, NJ Miller, L Annamalai, ... New England Journal of Medicine 374 (26), 2542-2552, 2016	1371	2016
Evolutionary dynamics of cancer in response to targeted combination therapy I Bozic, JG Reiter, B Allen, T Antal, K Chatterjee, P Shah, YS Moon, ... elife 2, e00747, 2013	721	2013
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma EJ Lipson, CG Drake Clinical cancer research 17 (22), 6958-6962, 2011	694	2011
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody EJ Lipson, WH Sharfman, CG Drake, I Wollner, JM Taube, RA Anders, ... Clinical Cancer Research 19 (2), 462-468, 2013	672	2013
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors FB Cortazar, KA Marrone, ML Troxell, KM Ralto, MP Hoenig, JR Brahmer, ... Kidney international 90 (3), 638-647, 2016	648	2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy L Heinzerling, PA Ott, FS Hodi, AN Husain, A Tajmir-Riahi, H Tawbi, ... Journal for immunotherapy of cancer 4, 1-11, 2016	554	2016
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer CG Drake, EJ Lipson, JR Brahmer Nature reviews Clinical oncology 11 (1), 24-37, 2014	548	2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus, and overall survival EJ Lipson, JG Vincent, M Loyo, LT Kagohara, BS Luber, H Wang, H Xu, ... Cancer immunology research 1 (1), 54-63, 2013	451	2013
Cardiovascular toxicities associated with immune checkpoint inhibitors JR Hu, R Florido, EJ Lipson, J Naidoo, R Ardehali, CG Tocchetti, AR Lyon, ... Cardiovascular research 115 (5), 854-868, 2019	433	2019
Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy P Nghiem, S Bhatia, EJ Lipson, WH Sharfman, RR Kudchadkar, AS Brohl, ... Journal of Clinical Oncology 37 (9), 693-702, 2019	408	2019
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab LC Cappelli, AK Gutierrez, AN Baer, J Albayda, RL Manno, U Haque, ... Annals of the rheumatic diseases 76 (1), 43-50, 2017	404	2017
Antagonists of PD-1 and PD-L1 in cancer treatment EJ Lipson, PM Forde, HJ Hammers, LA Emens, JM Taube, SL Topalian Seminars in oncology 42 (4), 587-600, 2015	343	2015
Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma L Chen, J Douglass, L Kleinberg, X Ye, AE Marciscano, PM Forde, ... International Journal of Radiation Oncology* Biology* Physics 100 (4), 916-925, 2018	329	2018
Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1 … PA Ascierto, I Melero, S Bhatia, P Bono, RE Sanborn, EJ Lipson, ... Journal of Clinical Oncology 35 (15_suppl), 9520-9520, 2017	279	2017
Tumor regression and allograft rejection after administration of anti–PD-1 EJ Lipson, SM Bagnasco, J Moore Jr, S Jang, MJ Patel, AA Zachary, ... New England Journal of Medicine 374 (9), 896-898, 2016	276	2016
Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer TJ Williams, DR Benavides, KA Patrice, JO Dalmau, ALR De Ávila, DT Le, ... JAMA neurology 73 (8), 928-933, 2016	274	2016
Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma SY Cho, EJ Lipson, HJ Im, SP Rowe, EM Gonzalez, A Blackford, ... Journal of Nuclear Medicine 58 (9), 1421-1428, 2017	255	2017

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere